Literature DB >> 29500747

Welcoming the new WHO classification of pituitary tumors 2017: revolution in TTF-1-positive posterior pituitary tumors.

Makoto Shibuya1.   

Abstract

The fourth edition of the World Health Organization classification of endocrine tumors (EN-WHO2017) was released in 2017. In this new edition, changes in the classification of non-neuroendocrine tumors are proposed particularly in tumors arising in the posterior pituitary. These tumors are a distinct group of low-grade neoplasms of the sellar region that express thyroid transcription factor-1, and include pituicytoma, granular cell tumor of the sellar region, spindle cell oncocytoma, and sellar ependymoma. This short review focuses on the classification of posterior pituitary tumors newly proposed in EN-WHO2017, and controversies in their pathological differential diagnosis are discussed based on recent cases.

Entities:  

Keywords:  Granular cell tumor; Pituicytoma; Posterior pituitary tumor; Spindle cell oncocytoma; WHO classification of endocrine tumors

Mesh:

Substances:

Year:  2018        PMID: 29500747     DOI: 10.1007/s10014-018-0311-6

Source DB:  PubMed          Journal:  Brain Tumor Pathol        ISSN: 1433-7398            Impact factor:   3.298


  10 in total

Review 1.  Advances and controversies in the classification and grading of pituitary tumors.

Authors:  E R Laws; D L Penn; C S Repetti
Journal:  J Endocrinol Invest       Date:  2018-06-01       Impact factor: 4.256

2.  Management of pituicytomas: a multicenter series of eight cases.

Authors:  Etienne Lefevre; Schahrazed Bouazza; Franck Bielle; Anne-Laure Boch
Journal:  Pituitary       Date:  2018-10       Impact factor: 4.107

Review 3.  Primary tumors of the posterior pituitary: A systematic review.

Authors:  Fernando Guerrero-Pérez; Agustina Pia Marengo; Noemi Vidal; Pedro Iglesias; Carles Villabona
Journal:  Rev Endocr Metab Disord       Date:  2019-06       Impact factor: 6.514

4.  Recommendation to improve the WHO classification of posterior pituitary tumors as a unique entity: evidence from a large case series.

Authors:  Nidan Qiao; Haixia Cheng; Zhaoyun Zhang; Hongying Ye; Ming Shen; Xuefei Shou; Xiaoyun Cao; Hong Chen; Xiang Zhou; Yongfei Wang; Yao Zhao
Journal:  Endocr Connect       Date:  2022-06-17       Impact factor: 3.221

5.  Rare neurohypophyseal tumor presenting as giant pituitary macroadenoma with cavernous sinus invasion - A case report and review of literature.

Authors:  Akhil Mohan; Prakasan Kannoth; Chandramohan Unni; Byjo Valiyaveetil Jose; Rajeev Mandaka Parambil; B N Nandeesh
Journal:  Surg Neurol Int       Date:  2020-08-29

6.  Surgical resection of granular cell tumor of the sellar region: three indications.

Authors:  Abdul-Kareem Ahmed; Hassan Y Dawood; David J Cote; Tejus A Bale; Umberto De Girolami; Edward R Laws; Timothy R Smith
Journal:  Pituitary       Date:  2019-12       Impact factor: 4.107

Review 7.  A rare case of pituicytoma presenting with severe Cushing disease: A case report and review of literature.

Authors:  Xiaoman Li; Yang Liu; Yuan Miao; Jinping Wang; Liang Wang; En-Hua Wang
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

Review 8.  How to Classify and Define Pituitary Tumors: Recent Advances and Current Controversies.

Authors:  Congxin Dai; Jun Kang; Xiaohai Liu; Yong Yao; Haijun Wang; Renzhi Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-17       Impact factor: 5.555

9.  Clinical features, radiological profiles, pathological features and surgical outcomes of pituicytomas: a report of 11 cases and a pooled analysis of individual patient data.

Authors:  Jian-Hua Cheng; Ding Nie; Bin Li; Song-Bai Gui; Chu-Zhong Li; Ya-Zhuo Zhang; Luigi Maria Cavallo; Peng Zhao
Journal:  Mil Med Res       Date:  2021-07-02

Review 10.  Case Report: Sellar Ependymomas: A Clinic-Pathological Study and Literature Review.

Authors:  Liyan Zhao; Yining Jiang; Yubo Wang; Yang Bai; Liping Liu; Yunqian Li
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-08       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.